Lot Size for investing in shares revised to 500 from current 2000 w.e.f 30 Oct Gujarat (India), October 31: Infinium Pharmachem Ltd, engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported a standalone net profit of Rs. 6.13 crore for H1FY24 ended September 2023 with Y-o-Y growth of 22.7% as compared […]
Continue Reading
Mr. Sanjaykumar Patel, Managing Director, Infinium Pharmachem Ltd Gujarat (India), August 3: Infinium Pharmachem Ltd, engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has approved 1:1 bonus issue at its board meeting held on 02 August 2023. Company has fixed 13th September, 2023 as the record date for the purpose of bonus issue. […]
Continue Reading
Mr. Sanjaykumar Patel, Managing Director, Infinium Pharmachem Ltd Gujarat (India), May 18: Infinium Pharmachem Ltd, engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported net profit of Rs. 9.49 crore for FY23, with Y-o-Y growth of 55.4% as compared to the net profit of Rs. 6.10 crore in FY22. Revenue from […]
Continue Reading